VANDYMOS Trademark

Trademark Overview

On Thursday, July 19, 2018, a trademark application was filed for VANDYMOS with the United States Patent and Trademark Office. The USPTO has given the VANDYMOS trademark a serial number of 88044781. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 13, 2021. This trademark is owned by VIELA BIO, INC.. The VANDYMOS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the treatment of rare autoimmune diseases and disorders
vandymos

General Information

Serial Number88044781
Word MarkVANDYMOS
Filing DateThursday, July 19, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 13, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 18, 2018

Trademark Statements

Goods and ServicesPharmaceutical products for the treatment of rare autoimmune diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 24, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVIELA BIO, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20878
Party NameVIELA BIO, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20878

Trademark Events

Event DateEvent Description
Monday, September 13, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 13, 2021ABANDONMENT - NO USE STATEMENT FILED
Wednesday, February 10, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 8, 2021EXTENSION 4 GRANTED
Monday, February 8, 2021EXTENSION 4 FILED
Monday, February 8, 2021TEAS EXTENSION RECEIVED
Wednesday, August 12, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 10, 2020EXTENSION 3 GRANTED
Monday, August 10, 2020EXTENSION 3 FILED
Monday, August 10, 2020TEAS EXTENSION RECEIVED
Friday, January 17, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 15, 2020EXTENSION 2 GRANTED
Wednesday, January 15, 2020EXTENSION 2 FILED
Wednesday, January 15, 2020TEAS EXTENSION RECEIVED
Wednesday, July 17, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 17, 2019EXTENSION 1 GRANTED
Wednesday, July 17, 2019EXTENSION 1 FILED
Wednesday, July 17, 2019TEAS EXTENSION RECEIVED
Tuesday, February 12, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 18, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 18, 2018PUBLISHED FOR OPPOSITION
Wednesday, November 28, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 7, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 6, 2018ASSIGNED TO EXAMINER
Tuesday, July 24, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, July 23, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

vandymos diseases disorders autoimmune rare products treatment pharmaceutical